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1 ..

INTRODUCTION
In the past few years the condition known
as agranulocytosis hE-s apparently bc;cc,II!e much
more common, both in this country and abroad.
Its dramatic symptons and signs, together with
its high mortality rate, have brought the disease into sharp relief and have resulted in occasional expression of clear cut opinions as to
its etiology, p2tthology, and treatment which are
not, in all instances, entirely justified.

In

spite of our recently acquired familiarity with
the disease, it still remains a mystery in many
respects.
Certain ruchors, Rose and Houser (1), Brogsitter and Von Kress (2), Zikowsky (3), Aubertin
and Levy (4), regard the disease not as a clinical entity but rath,;r as a syndrome common to
many pathological conditions and their view may
yet be proved correct.

Befc)re this question can

be definitely answered a large number of cases
must be carefully studied both from a clinical
and a pathological point of view.
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Rose and Houser (1) give a number of arguments in support of their belief that agranulocytosis is not a specific entity and their
reasoning is similar to that of many authors
who hold the same view.

Leukopenia occurs,

they say, under many conditions.

Yet the fact

that anemia occurs under many circumstances
does not militate against the fact that pernicious anemia is an entity.

They point out

that there is no knov-n etiological agent for
agranulocytosis and that the condition has not
been exactly reproduced in animals; yet it does
not follow from these facts that there is no
such disease.

The etiology of myelogenous leu-

kemia is unknown, nor has it been exactly produced in animals.

Consequently I do not be-

lievesuch arguments can so easily dispose of
such a difficult question.
That extreme leukopenia and neutropenia
alone does not constitute valid criteria for
the establishment of a single disease should
be obvious.

Several authors, Brogsitter and

Von Kress (2), Blumer (5),

-

Pepp(~r

(6), Jackson

(7), and Doan (8), have pointed out that
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hematological pictures similar to that seen in
agranulocytosis may be found in many diverse
conditions,

Yet because one disease may easily

be confused with others does not argue that the
first is not an entity.
Brogsitter (2), in a consideration of agranulocytosis, lists thirty-four patients with marked
leukopenia and grEnulopenia in which the hematological picture was directly traceable to some
other underlying cause.

However, in this series

of cases, fifty percent were males and in this
fifty percent there

~ere

nineteen with noticeable

anemia and in seventy-eight percent of the cases
the platelets were markedly diminished.

These

are not characteristic findings of true agranulocytosis.

Doan (8) believes that only twenty

percent of the cases referred to his clinic with
leukopenia could be regarded as falling into the
narrow classification of true agranulocytosis,
while Metteir (9) in a study of 1167 cases of
leukopenia, found on:j.y six perc -'nt in which the
cases were not explainable on the basis of some
well recognized disease, of which the leukopenia
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was but one striking sign.

Moderate leukopenia

is seen in the course of many infections; extreme; l";ukopenia may occur as a sequel to over
whelming sepsis; it is seen as a result of Benzol poisoning and may be due to the toxic affect of gold, bismuth or arsenic; it is a prominent feature in aplastic anemia; it is not
uncommon in severe pernicious anemia and is occasionally seen in both acute and chronic leukemia.

There is no doubt but that the majority

of patients with leukopenia have some well recognized fundamental disorder to account for this
hematological abnormality and furth·c;r that this
disorder is" in some instances unrelated, primarily to the hematopoetic system.

Lack of apprec -

iation of these undoubted facts necessarily leads
to false thinking as regards the etiology, pathology, and treatment of the disease or syndrome,
agranulocytosis.
Acute leukemia in the aleukemic phase very
closely simulGtes agranulocytosis and the two
diseases are not infrequently mistaken one for"
the other, (10), (11), (12).

In fact, at the
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present, the re..;.stionship of the two conditions
must be regarded as problematical.

Yet there

would appear to be certain essential differences.
Absence or marked dim±nution of platelets, anemia
of moment, particularly if progressive, hemorrhages,
especiall.v from the mucous membrC'nes of the mouth
notable enlargement of the spleen and enlargement
of lymph nodes, not readily explainable by adjacent ulceration and infection, all indicate acute
leukemia.

In acute leukemia, especially in adults,

the blood smear shows a considerable number of very
immature cells; often virtually all the while blood
cells are stem cells [,nd it is only in the most
atypical cases that young forms are few in number,
an occasional stem cell may be found in the blood
of pc,tients suffering from agranulocyt sis.

Any

very considerable number, however, indicates the
probability of a leukemia and the more there are
the

~reater

the probability_

A level is reached,

which is more than tem?orary, almost certainly
means leukemia.

DUring convalescence from agran-

ulocytosis there may be, and in fact usually is,
a transient outpouring of myelocytes, but this
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stage is soon passed and clinical improvement
is coincidentally evident.
Leukemic patients with temperatu:':'es of
102 degrees to 104 degrees F may seem comparatively well.
ulocytosis.

This is rarely the case in agranIn this latter disease such tem-

peratures are almost invariably accompanied by
marked prostration and symptoms of toxicity.
In agranulocytosis, the fever is either steady
or, more commonly, fluctuates within certain
defini te rather rather limits.

In cccute leu-

kemia the temperature curve if often an extremel¥ variable one.

Afebrile periods are

not rare, even at the height of the disease.
It must be emphasized that the total white is
of no vital importance in the diagnosis of
leukemia '."h:"ther the ',o,hi te count be 500 or
50,000 per c.mm.

The character of the white

cells, the concomitant alterations in the
red cells, and platelet picture and the pathological changes in the bone marrow determine
the diagnosis and serve, at least in the maj-
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qrity of instances, to mark the one from the
other disease.

Acute leukemia, furthermore,

is the more likely the younger the patient
and it is probable that the majority of the
extreme leukopenias in children are traceable to leukemia or to some serious disorder
of the myeloid system other than true agranulocytosis.
Those cases showing very low red cell
counts depart more obviously from true agranulocytosis.

The lower the red cell count the

less likely the disease is to be true agranulocytosis.

With marked anemia, pancytopenia

or pernicious [J.nemia with an unusually low

\'lhi te

cell count is the more likely the diagnosis,
but in certain instances the white cells in the
peripheral blood of patients with pancytopenia
fall far more rapidly and to a much greater extent than do the other formed elements and if
sepsis should ensue one may have as in a case
cited by Jackson and Parker (13) a

~cture

closely resembling true agranulocytosis.

more
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However, this condition can be distinguished
as a rule from agranulocytosis by the paucity
of platelets, the progressive anemia, the presence of at least a few neutrophils in the peripheral blood and a tendency to bleeding from
the mucous membranes.

Yet, as with aleukemic

leukemia, there may arise great difficulties
as it is well within the realms of possibility
that one disease may shede into the other.
Bearing in mind these diagnostic and nosological difficulties it does seem, however,
that,

aft~r

discarding the extreme leukopenias

secondary to sepii"

a leukemic leukemia, a

plastic cmemia, pancytopenia and leukopnias
of certain metastatic bone tumors, a senic, gold
and benzol poisoning, there remains what for lack
of a better term may be called agranulocytosis,
agranulocytic angina or idiopathic malignant
neutropenia..

It is of this condition that I will

discuss as to its etiology, pathology and treatment.

9.

ETIOLOGY
The majority or the earlier authors regarded agranulocytosis as a direct result of
overwhelming infection,Brogsitter (2).

Yet

geadually this point or .view has been changing and there would seem to be considerable
evidenee that sepsis is not the cause, but
rather the result of the disease.

That such

is the case is atestedto by the fact that
the white count has been found by many auth.;"o
ors to be lowered ror several days before any
clinical signs or symptoms have been man1rest.
In a case or Jackson and Parker (13) the white
count was 500 per c.mm. or lower for four days
berore the appearance of any clinical signs or;i
symptoms whatsaver.

On the rifth day the pat-

ient had an abrupt rise of temperature to 104
degrees F., chills, headache, prostration and
severe sore throat.

Bacteria has succesfully

invaded a defenseless organism.

I believe it

is difficult to invision an infection so potent
as to virtually abolosh lwukopoiesis without
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at the same time giving rise to some other outward
and visible sign or symptom.

It is more logical

to assume that the depletion of the available leukoeytes renders the organizm liable to infection
of a most virulent sort.

This

belief~has

been

frequently expressed (6), (7), ,(8), (11), (14),
and (16).

Furthermore, in those instances in

which infection appears to be the true cause of
the leukopenia, the differential white count and
histological picture in the bone marrow are quite
different from that seen in agranulocytosis.

In

overwhelming sepsis the total perepheral white
count may indeed be very low but polymorphonuclear
neutrophils usually form a large percentage of
the remaining cells.

Myelocites and young polys

are common, even at the height of the leukopenia.
In the unusually active bone marrow all stages
of myelopoiesis are seen.

Such a pathological

picture is never seen in agranulocytosis wbBn
the disease is at its height.

In this condit-

ion,the neutrophils virtually disappear from
the pertpheral., blood and in the bone marrow
no forms more mature than stem cells, or at

-
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best promyelocytes, are seen unless there has
already been blood regeneration and the patient has died of some complication, as is occasionally the case.

These pathological changes

will be discussed in detail later.
Overwhelming infection can in all probability be discarded as a common cause of true
agranulocytosis.
Pepper (6) has suggested allergy to be of
etblogical importance in the production of agranulocytosis.

However, little has been written

to substantiate his suggestion.
Jackson, Merrill, and Duane (17) and also
Thompson (18) have suggested that some endocrine
disturbance is the basis fur tae condition by the
fact that in many instances the disease occurs
at the time of menstruation.

Thayer and Hansen-

Pruss (19) reported a case in which attacks occuned regularly for over twenty years at approximately

twenty~five

day intervals.

This

case would seem almost certainly to be of
glandular origin.

It is doubtful, however,
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whether any very large percentage of the cases
may be definitely traced to an endocrine disturbance.

Thayer~

patient appears to be unique

and the fact that many female patients suffer
from remissions or attacks at the onset of
their catamenias dOGS not necessarilly lay any
very solid foundation for an endocrine etiology
of the disease.
~he

fact that agranulocytosis has increased

markedly in recent years together with the known
leukotoxic effect of the benzene ring, makes most
tempting the theory that some, if not all, cases
are due to the administ'ration of emidopyrine and
allied drugs, therapeutic agents which have lately
become more and more widely used.

Madison and

Squier (20) draw the following conclusions from
fourteen cases cited in their recent article.
First, the increase in incidents primary granulocytopenia has paralleled the increase in the use
of drugs containing amidopyrine and espeCially
those containing

amidopyrin~

with a barbiturate.

Second, the disease has appeared most frequently
in persons apt to be taking drugs:

physiCians,
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nurses, and those directly under the care of a
physician.

Third, in each of fourteen patients

the onset of primary granulocytopenia was directly preceded by the use of amldopyrine alone
or in combination with a barbiturate.

Fourth,

the mortality in a group of six patients who
continued the use of drugs cuntaining amidopyrine
was 100 percent.
who did not

In a group of eight patients

c~ntinue

the use of the drugs, only

two died, and both died of the initial attack.
Fifth, the administration of a single dose of
amidopyrine to each of two patients who had recovered from the acute disease was followed by
a rapid fall in granulocytes.

Hoffman, Butt

and Hickey (21), Watkins (22) and others have
dravlln attention to a similar relationship between the drugs and the disease.

Seeman

~23)

however, noted that in thirteen of twenty-six
cases amidopyrine or its allies had been taken,
yet in fifteen there was definitely no history
of such therapy.

Similarly Jackson (24) in an

analysis of twenty-seven of their cases in
which complete and unequivocal data relative

14.

to medication were at hand, found that in only
seven of them could the disease be properly regarded. as directly traceable to the administration of the compounds.

There can be no

question but that amidopyrine or its allies
are of etiological importance, particularly as
Madison and Squier (20) have produced with these
drugs mild and transient, but definite granulopenia in patients who had recovered from a classical attack.

But there is also no question

but that in many other instances

tt~€is

explanation of the cause of the disease.

no such
Further-

more; it has been pointed out that the drug may
be taken in considerable amounts prior to the onset of the disease.

Yet on careful analysis it

may appear that it is of no etiological importance whatsoever..
studied by Jackson

Eight of twenty-seven cases
(2~)

had taken amidopyrine

or allied compounds in considerable quantities,
yet it could be shown in these instances that
the therapy had not the slightest causal relation to the actual disease.

Therefore, it

is safe to say that the etiological importance
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of these drugs is undeniable, but they certainly
are not the sole cause of the disease.

A spec-

ial rel,;ort of the Council on Pharmacy and Chemistry of

~he A~erican M~dical

Association (25)

concludes that 'there is, Tlno question that amidopyrine is very important in the production of
granulocytopenia".

The report does not say,

nor does.oi t imply, that all cases are due to the
drugs, nor do"es it preclude the possibility
that there may be some pre-existing bone marrow dyscrasia which affords a fulcrum upon which
the drug may work.
In a similar manner dinitrophenol has been
shown to be the apparent cause of the disease
in certain instances.

Bohn (26), Davidson (27),

Dameshek (28) and Silver (29) hqve substantiated
this belief.

This drug must therefore also be

regarded as potentially dangerous, even in therapeutic doses.
seen.

A familial tendency is rarely

In the articles that I have reviewed,

I could find no suggestion in the histories of
cases that would suggest familial tendencies.
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Th€,refore, when all is summed up, it
must be oonfessed that the etiology of this
disease still remains, in large part at least,
obscure.

That some cases appear to be caused

by the administration of certain chemicals or
by th-c 3ction of certain toxins should not be
regarded as indicating that the disease is but
a syndrone.

Pernicious anemia may be due to

lack of an intrinsic factor, to radical surgical -interference with the gastrc-intestinal
tract or t9 malignant disease preventing the
proper functioning of such factors as cause
a proper maturation of the red cells.

In

a similar manner a variety of agents, known
and unknov:n, may prevent proper maturation of
the granular white cells and so produce the
disease, agranulocytosis.
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PATHOLOGY
The pathology of this disease is in dispute.

Much of this confusion arises from fail-

ure on the part of many even to attempt the differentiation, either clinically or pathologically,
of the various conditions giving rise to the striking but far fvom pathoneumonic

s~gn,

that of ex-

treme granulopenia.· Ccnfusion also arises from
too great reliance being placed on the interpretation of stained smears taken from the bone
marrow.

Such smears are of importance in iden-

tifying certain cetls not easily recognized in
sections

sta~ned

with eosin-methylene-blue.

But

from smears of bone marrow one gets absolutely
nO.idea of the number

or~rangement

of the cells

and upon such factors, as well as upon the nature
of the individual cells, the diagnosis of any marrow lesion is based.

-.

have

ex~ressed

Custer (30) and Peabody (31)

this opinion.

Roberts and Kracke

(16) say, "there is an unanimity of opinion that
the essential pathology is a marked hypoplasia of

.-

the

myelo~ytic

tissu~s".

In one of their cases
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sternal puncture (smears) showed a marrow en-

-

tirely devoid of granular cells of any type,
including even myeloblasts.

In the photomi-

crograph illustrating this feature one would
be at a loss to, identify any cell according
to one author.

Dodd and Wilkinson (32) state

that the bone marrow is aplastic, but it should
be pointed out that they describe the marrow
of a colored girl of eleven years with hereditary syphilis who af'ter treatment with sulpharsphenamine developed extreme leukopenia.

The

condttion can hardly be regarded as one of true
idbpa tl~ic agranulocytos1s •

Schultz, who orig-

inally described this disease entity, is of'ten
quoted as belie.ving the marrow to be ap+astic.
Yet Leon (33), who described the marrow in
Schultz's cases, merely says that there were
neither mature neutrophils nor myelocytes to
be f'ound and that the femur was partly red,
partly f'atty.

Such

s~atements

can not be con-

strued as indicating that the author considered
the·marrow "aplastic".

In other instances when
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the marrow is said to be aplastic, examination
of the original sources discloses the fact that
in the case under consideration the tibia or
midfemur was examined.

It is not surprising,

therefore, that the histological picture of the
disease is regarded as c:";nfusing.
Jaffe (34) found the bone marrow rather
more cellular than normal with signs 6f marked
degeneration in the granules of the myelocytes.
These granules were said to "fuse with the cytoplasm".

Jaffe believed the majority of the white

cells "to be myelocytes with a moderate or considerable number of plasma cells and lymphocytes.
Megakaryocytes, he found in normal or in increased
numbers.

Fitz-Hugh and Krumbhaar (35) in a most

important contribution, postulate a maturation
arrest at the stem cell stage with the added possibility of an end stage which might be regarded
as aplastic.

This seems to be the general trend

of thought.
Jackson and Parker (52) studied the marrow
of twenty-five cases which they diagnosed as agranulocytosis.
made.

The following generalizations were

The marrow of the ribs, sternum and midfemur
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and vertebrae was essentially the same.

The

degree of cellularity was usually normal.
Rarely the femur remained fatty, as ip the normal adult.

It would seem that in these instances

death occurred too soon for the marrow activity
to spread

per~pherally,

although this view is

not entirely agreed upon.

In some sternal and

vertebral marrows, particularly in patients dying later in the disease, a certain amount of
hypoplasia existed.

On the other hand in the

fulminating cases the marrow was perhaps unusually rich in cells.

The

degre~

of cellul-

arity, however, varied but little and is, they
believe, an unessential feature of the condition.
There was little or no disturbance in the red
cell series.

E1,'ythroblasts, normoblasts and

nucleated reds occurred in normal or slightly
increased numbers and showed no abnormal features.

.-

The megakaracytes also were found in

the usual numbers and histologically appeared
perfectly normal.

With this latter finding

of Jackson and Parker, Rotter (36) and Jaffe
(34) agree.

This seems important since
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Roberts and Kracke (16) believe that they hemorrhagic tendency which they regard as a very
common

sYmp~om

to be due to marrow disfunction

involving megakaryocytes and a decrease bf
platelet

formation~

Most

~~iters

have not found

such a dtscrasia to exist.
The most marked bone marrcw changes naturally occurr in the cells of the granular series.

No mature granulocytes, either neutrophils

or eosinophi1s,are found in the marrow, nor is
there any true myelocytes.

Practically every

cell that belongs to the granular series is a
stern cell.

The other cells found ar.e plasma

cells or lymphocytes.

That this may be con-

strued as a maturation arrest, Fitz-Hugh and
Krumbhaar (35), rather than failure to

de~iver,

is evidenced by the fact that the parent cells
were often inactive mytosis.

These stem cells

seem to be able to produce their own kind of
profusion.

Further maturation is denied.

Rotter (36) finds that in those patients
who survive the ravages of infection for a
considerable period (eight to twenty days) the
bone marrow picture was somewhat different.
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It was found to be relatively hypoplastic ..
Gradua~-ly

as the disease progressed, the stem

cells diminished in number and their place
was taken by lymphocytes and plasma cells and
in cases dying as late as the fifteenth day
after the apparent onset of the disease, the
cells constituted virtually the only white
cells in the marrow.

This late stage would

appear to correspond to the terminal "ap+astic"
stage postulated by Fitz-Hugh and Krumbhaar (35).
Phagocytic macrophages were at all times present
in considerable numbers, particularly in the late
stages of the disease.

Such cells have also been

remarked upon by Jaffe (34).
It must be recognized that until further
work is done we cannot speak dogmaticall¥ of the
patho~ogy

of the disease, the nature of which is

still obscure.

At present the view of Fitz-Hugh

and Krumbhaar regarding a maturation arrest with
a predominance of lymphocytes and plasma cells
seems most likely.
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TREATMENT
, The treatment of any disease, the pathogenesis and nature of which is uncertain,
is~t

best unsatisfactory and the more so when

that condition ma:r be easily confused with
other pathological entities of probably a different fundc;.mental nature.

Many measures have

been advocated to combat agranulocytosis.
is specific.

Most all

authori~ies

agree

None
that

the major problem is that of rest9ring the bone
marrow to its normal activity and thus raising
the peripheral white count; f"or the loss of leukocytes removes one of the body's great defenses
against infection.

Without bone marrow recovery,

there can be no cure.
Non-specific therapy, suchm the injection
of sterile milk or turpentine, is conceded by almost everybody to be useless.

~hat

one gets a

white cell response in normal patients by such
therapy is not the slightest reason for supposing
that a similar response should occurr in agranulocytosis.

The probable affect of such treat-
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ment in patients with normal bone marrows, is
chemotactic, that is. the calling force of such
mature and slightly young :)olys as are readily
available in the bone marrow, and their rapid
and efficient replacement.
troph~ls

There are no neu-

in the bone marrow of

a~ranulocytic

patients to call forth.
Transufsion of blood has been endorsed
by some, (1) and (6), and without question recoveries have ftilowed one or more such transfusions.

Aside from the f&ct that there is

not good evidence that blood transfusion has
a stimulating affect in

agranulocytosis~

In-

deed, it is not uncommon experience to find
the peripheral white count definitely lower
after transfusion than before.

The number of

white cells actually given the patient is
small; their life short; and further more, the
patient, as a rule does not need either plasma
or red cells.

In the presence of sepsis, when

the white count has risen to normal or abnormally high levels, small multiple
be of value.

tran~sions

may

There seems to be little convinc-

ing evidence that they ·tend permanently to raise
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the white count or stimu1"l te the marrow.
Stimulating doses of X-Ray were advocated by Freidemann and E1ke1es (42).
treated forty-three patients.

They

Of these,

twenty-three either had sepsis or pneumonia
or died within thirty-:-six hours and all were
discarded by Fnidemann and Elkeles in evaluating the

e~cts

of roentgen therapy.

Of

the twenty remaining cases there appear to
be but seventeen individuals and of these
eight died, a mortality of forty-seven percent.
It should be recorded for accurate comparison
of mortality statistics that in the complete
unexpurgated series the mortality was eightytwo percent.
Taussig and Schnoedelen (43) treated
four cases by X-Ray with a mortality rate of
fifty percent.

Other authors unenthusiastically

recommend radiation.

Reznikoff (44) has expressed

the opinion that even small doses of X-Ray tend
to qepress the bone marrow and he points out that
four or five days must elapse before the effects
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of any maturant agent can be seen, in the peripheral blood.

It is usually claimed by those

who advocate radiation therapy that hematological changes of a favorable sort were seen
in the peripheral blood in a few hours.

"fuen

such changes have occurred, according to Reznikoff (44) it is due to either a re-distribution phenomena or a spontaneous rise and not
to genuine stimulation of a dormant or sup:pressed marrow.

Pepper (6) is not enthusiastic

about radiation therapy.

Dameschek (10) treat-

ed twenty cases with improvement in seven, but
a year later only two were living, giving a
tality rate of ninety percent.

mq~

Therefore, I

would say that a criti941 analysis of the results of radiation therapy does not seem to afford any very convincing evidence of its value.
Roberts and Kracke (16) believe that "sepsis
and necrosis are the great hope of every patient
with complete granulopenia".
this hope is often fulfilled.

It seems to me that
These same authors,

however, say that "there is death unless granulocytes reappear".

The implication appears to be
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that sepsis and necrosis in and by themselves
stimulate the marrow to regeneration and thus
restore the leukoeytes to the peripheral circul&tion.

It 1s difficult to prove dherwise

but it certainly seems unlikely.

That sepsis

raises the white count in individuals with a
normal marrow is no indication that it will do
so in one whose bone marrow contains as far as
white cells are concerned, only stem cells.
Just how sepsis causes leukocytosis and a hyperplastic marrow in normal p&tients is not clear.
There is no evidence, however, that it does so
by stimulating the few pre-existant stem cells
to maturation.

The sepsis of agranulocytosis

is admitted by all to be the result (not the
cause) of leukopenia.

Those authors with wide

experience in the disease have seen cases in
which ttle peripheral white count

has risen

co-incidentally with the development of abscesses.

It does not follow that the abscess

caused the hematological improvement.

No one

has suggested giving pyogenic organisms intramuscularly as a therapeutic agent.

Many authors
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report a white cell

eleva~on

coincidentally

with the development of the outward and visible
signs of sepsis and, ,if the peripheral blood
be carefully followed, they report often, a
sudden drop of leukocytes with abscess formation and to be followed again, in a few hours
or days, by a prompt rise to the previous level
or even higher level.

According to Jackson and

Parker (33) the bacteria have been present all
along, but no white cells have been available.
"Laudable" pus could not be formed; no "abscess"
could develop.

The return of bone marrow ac-

tivity supplies these white cells and they have
been immediately drawn to the sight of infection,
thus temporarily depleting the supply in the peripheral circulation.

Hence the transient fall

in peripheral white count.

Further investigat-

ion in this aspect of the disease reveals that
agranulocytosis has developed, in the presence of
pre-~xisting

and patent sepsis.

Millmann and

Furculo's (38) patient "was stricken in her second attack during a time when she was suffering
from two abscesses in the gluteal region".

This.
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would tend to indicate that in

thi~

case, at

least, abscess formation which has been advocated as a method of treatment of agranulocytosis
was of no benefit.

Therefore, in this review of

the literature, the evidence that sepsis and necrosis in cases of agranulocytosis bring about
a regeneration of the marrowE not convincing.
Liver extract has been advocated by Foran
(45).

He injected the equivalent of one hundred

grams of liver into the vein or muscle every eight
to twelve hours until a definite rise of total
whitecpunt had taken place.

Four cases apparent-

ly true agranulocytosis were successfully tre.ated.
Coggeshall (46) injected six vials of liver extract (Lilly 343) intravenously each day.
cases failed to respond.

His

Silver (29) treated a

case of agranulocytosis due to dinitrophenol with
liver without beneficial results.

Bonsdorff (47)

treated two cases with liver intravenously with

.-

recovery in both instances.

However, his first

case was evidently pernicious anemia.

She had

a red count of 528,00 per c.mm., a color index
of 1 .. 32 and a white count of 1,750.

His second

patient had extreme leukopenia, apparently due
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to novarsenobenzol and bismuth..

The withdrawal

of these drugs may well have had as beneficial
an effect as liver extract.

Bonsdorff (47) im-

plies that because the white

ce~l

count rises

in pernicious anemia following liver therapy,
it should rise in agranulocytosis.

Yet the mech-

anism of leukopenia in pernicious anemia is not
known.

It may be that it is similar to that

which produces the anemia in leukemia, mmely a
crowding out of one series of cells by an overgrowth of another.

If this is so , liver

thE~rapy

would raise the white count in pernicious anemia
by an indirect rather than by a direct method.
Therefore, summing up this phase of the treatment, we may say-that spme few cases have been
successfully treated with liver extract, but
the ultimate value of this drug at the present
time cannot be estimated.
In 1930 Reznikoff (48)< advocated the use
of adenine sulphate (one of the breakdown products of Pentnucleotide) in the treatment of
agranulocytosis and in 1933 Reznikoff (49) summarized the results in fifteen cases with eleven
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recoveries.

He also treated eight cases in which

the diagnosis was doubtful with but one recovery
and twelve cases complicating other diseases with
two recoveries, and these were temporary.

His

conclusionsin so far as pure agranulocytosis were
concerned were conservatively optomistic.
In 1924 Jackson (50) definitely demonstrated
the presence of pentose nucleotide in normal human blood.

In as much as it has been shown by

Doan, Zerfas, Warren, and Ames (51)· in 1928, that
such products could raise the peripheral white
count in normal animals, Jackson (52) decided to
try the effects of this substance, presumably a
normal metabolite of the intact and healthy organizm, in those conditions characterized by extreme leukopenia.
In 1931 he (52) reported the

res·,~lts

of

such therapy in twenty cases of extreme leukopenia or neutropenia with fourteen recoveries.
In 1932 Jackson and Barker (53) reported an analysis of sixty-nine case~ including the original
twenty.

In the tdal series the mortality Was

only twenty-six percent •.
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Pentnucleotide (N.N.R.) may be given intramuscularly or intravenously.

In the average case

of' agranulocytosis v'li tll a white count between
1,000 and 2,000 per c.mm., 10 cc. of Pentmcleotide
are given intramuscularly two or preferably, three
times a day until the white count has definitely
risen and young neutrophils have appea,red.

This

change usually occurES on or about the fifth day
of treatment.

10 cc. are then given once a day

until the white count has been normal for several
days.

Most authors advocate in those patients

who are extremely sick and especially in those
in which the total white count is below 1,000
40 cc. should be given a day until the white count
has definitely risen and young neutrophils have
appeared.
tageously.

50 cc. may be given even more advanThe drug may also be administered

intravenously well diluted in saline by the continuous drip method, the speed of injection by
such that no untoward reactions occurr.

Usually

fifty to Qne hundred drops may be given a minute when 20 cc. of pentnucleotide are diluted in
1,000 cc. of normal saline solution.

The drug

should be continued in large doses until the
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white count has definitely risen and in somewhat smaller amounts until it

h~s

been normal

for several days, further therapy with pentnucleotide is useless, (53).
Usually there are no untoward reactions
of the patient to the drug.

In some there is

a transient sense 'of discomfort at the sight
of the-injection.

In others, there may be pre-

cordial distress, dyspenea or nausea.
are the symptoms alarming.

Rarely

If, however, they

are sufficiently severeto upset the patient the
individual dose may be reduced and the number of
injections per day correspondingly increased.
In this manner one can almost always give the required amount each day.

It is useless, especially

in severe cases, to give small doses.

The drug

should never be given to a patient with an anaphalactic history, nor to one with severe cardiac
damage.
Doan (37) states that in fC'!vorable cases the
first signs of improvement following pentnucleotide
therapy are evidenced by the appearance of myelocytes
in the blood stream.

These cells may reach twenty
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percent of the total white cells.

According

to most observers, this change usually occurs
on or about the fourth day of therapy and corresponds in certain measure to the reticulocyte
rise in pernicious anemia.

Shortly thereafter,

the temperature falls, the total white count rises
and more mature neutrophils take the place of the
immoture cells.
In one series of one hundred and three patients reported that were

treate~

in this way sixty-

nine or sixty-seven percent recovered and are still
alive (58).

Four additional patients recovered

from their initial attack but died in a subsequent
relapse.

Thus the mortality (thirty-three percent

for the entire series) is considerably lower than
that generally accepted for the untreated disease,
and considerably lower than that for any comparable
series treated by any other measures.
Schnoebelen

Taussig and

(45), in three hundred and thirty col-

lected cases give a mortality of seventy-six perc~nt,

and furthermore, they scored a recovery for

each and every remission.

The corrected mortal-

ity in their series would naturally be considerably higher.

Brogsitter (2) in 1930 found a mor-
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tality of seventy-seven percent in sixty-four
cases.

Fuld (54) in 1930 noted recovery in

but twenty-three cases out of two hundred and
forty-eight.

A mortality of ninety-one percent.

Uffenorde (40) found a mortality rate of seventyseven percent in 1934.

In 1934 Roberts and

Kracke (39) stated "complete granulopenia is usually a fatal disease during the first or a later attack", and these authors say that they
have not seen any of their recovered cases return to complete health.

Rosenthal (55) re-

ports ten cases with five recoveries.
Pentnucleotide (NNR) has been used with
apparent success by many, (8), (9), (10), (2'6),
(27), (38), (41), (56), (57), (58), (59), (60),
(61), (62), and (63).
Zia and

Fory~er

(64) have used it with con-

siderable success in cases of agranulocytosis,
complicating

Kala~azar.

They say, "It would

appear that the administration of pentose nuoleotide or purine basis offers by far the most
satisfactory treatment, not only for agranulocytosis but also for the conditions of agranulocytosis, the result of pyogenic infection
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or of. chronic benzene poisoning".
Others have had less success, (47), (65),
and (66).

In not all of these cases was the

diagnosis true agranulocytosis.
It is impossible at present to evaluate
properly the true usefullness of the drug.

It

appears to be harmless, even over long periods
of time.

The mortality of those cases treated

with it, seems to be definitely ·loweredcthan
that in any comparable senes treated by any
other means.

Certain confirmatory evidence is

brought forward by the extramudullary

~yelopoiesis

which may be brought about by its injection into
animals and the uniformity with which hematological improvement occurs about the fifth day of
treatment.

The possibility of spontaneous re-

mission must, however, always be born in mind
and any individual case cannot be easily dismissed.

Patients have received the drug in ad-

equate amounts and recovered only to relapse
again with complete therapeutic failure on the
second attempt,.(65).

Patients have received

the drug and failed to respond and then recovered
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spontaneously, (57).

However, the fact remains

that no other therapeutic agent has been shown
to be more efficient.
Zinniger (66) quoted above as being unenthusiastic about Pentnucleotlde, used liver,
iron, leukocytic extract, sodium nucleinate, adenine sulphate, and guanine with indi.fferent results.

Silver (29) reports a patient with twenty

percent neutrophils and ten percent monocytes that
died in spite of liver extract iherL'py.
(66) patient, who failed

m respond

Zinninger t s

to pentneucleo-

tide; died two months later, havi.ng just "responded"
to Addisin.
At present, it would seem that pentneucleotide,
provided there are no untoward reactions,offers
the best chance of recovery in a patient with agranulocytosis.
It stands to reason that intelligent bedside
care, careful nursing, adequate nourishij1ent, and
fluids are all a necessary and.obvious part of the
treatment.

The patient must be protected in so

far as possible from infection, but to attempt to
sterilize the ulcerated lesions.by·means of .
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antiseptics is fruitless.

Such constant ther-

apeutic nudging serves only to keep the pa.tient
awake when he should be resting, but frequent
washings of the mouth and throat with soothing
solutions may allay the pain, reduce the amount
of secretion and make the patient in general
more comfortable.
It h2.s been suggested by Beck (15), Roberts and Kracke (39), that surgical intervention is contraindicated.

However, in this re-

view, I would say that most authors disagree
and believe that such surgery should be undertaken as would be advised in a patient with
normal blood.
It is certain that all drugs containing
a benzene ring shoull be immediately and completely omitted.

Madison and Squier (20) found

one hundred percent in their six cases which
continued to take amidopyrine or its allies.
In certain instances, edema of the throat
may be so great that deglutition and even respiration may be difficult or impossible,

Trach-

eotomy has been tried in such instances, but I
believe most authors consider it of no avail.
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SUMMARY
1.

Whether agranulocytosis is to be regarded

as a disease entity or a syndrome cannot as yet
be dogmatically stated, but it is probsbl? that
such a disease entity does exist.
2.

The etiology of the condition must for

the present, remain uncertain.

Amidopyrine and

its allies, however, may and probably do have
much to do with the development of certain cases.
3.

The pathological changes in the bone mar-

row of agranulocytosis consist of a maturation .
arrest at the stem cell stage.

Later in the course

of the disease plasma cells and lymphocytes replaced, to a large extent, the previously existing
stem cells.
4.

Careful nursing and asepsis and intel-

ligent general care of the patient are obviously
essential and important parts of the treatment.
5.

Pentneucl.eotide (NNR) intramuscularly or

intravenously offers, at the present time; the best
method of stimulating the bone marrow to recovery
and the results following this therapy have been
more satisfactory than those after any other type
of treatment.
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